MINRESI: Valorizes Pharmacopée Traditionnelle "Made in Cameroon"

• A national colloquium on Cameroonian traditional pharmacopoeia opened on September 17, 2026, in Yaoundé I.
• MINRESI, represented by Secretary General Pr Rebecca Ebele Etame, led its delegation to the event.
• MINRESI views traditional pharmacopoeia as an opportunity to strengthen the 'Made in Cameroon' initiative and foster a national health industry.
• The colloquium brought together high-level government officials, researchers, academics, and traditional practitioners.
• This initiative aims to enhance Cameroon's health sovereignty and develop its local pharmaceutical sector.

MINRESI views traditional pharmacopoeia as a pivotal element for strengthening the 'Made in Cameroon' initiative, particularly within the health sector.

A significant national colloquium dedicated to the valorization of Cameroonian traditional pharmacopoeia commenced on Thursday, September 17, 2026, at the Amphitheater 700 of the Faculty of Medicine and Biomedical Sciences at the University of Yaoundé I. This event served as a crucial platform for discussions surrounding the integration and promotion of traditional medicine within the national framework, drawing high-level participation from various government ministries and academic institutions.

The Ministry of Scientific Research and Innovation (MINRESI) played a central role in the proceedings, with its delegation led by Pr Rebecca Ebele Etame, the Secretary General. Pr Etame represented Dr Madeleine Tchuinté, the Minister of Scientific Research and Innovation, underscoring MINRESI's commitment to this domain. The colloquium's opening ceremony was presided over by Pr Jacques Fame Ndongo, the Minister of State and Minister of Higher Education, highlighting the inter-ministerial importance of the initiative.

Further demonstrating the broad governmental and academic interest, the event saw the presence of Pr Marie-Thérèse Abena Ondoa, Minister of Promotion of Women and the Family, alongside a diverse assembly of researchers, academics, and traditional practitioners. This gathering provided a unique forum for reflection, exchange, and the sharing of experiences on what is considered an important aspect of national life, as articulated by Pr Etame.

MINRESI views traditional pharmacopoeia as a pivotal element for strengthening the 'Made in Cameroon' initiative, particularly within the health sector. Pr Rebecca Ebele Etame emphasized that this focus presents a significant opportunity to foster the emergence of a robust national industry dedicated to health and well-being products. This strategic direction aligns with Cameroon's broader objectives for achieving greater health sovereignty and reducing reliance on imported pharmaceutical goods.

The Ministry's engagement at the colloquium underscored its doctrine, which Pr Etame briefly recalled as "transfo." This doctrine appears to guide MINRESI's efforts towards transforming traditional knowledge into tangible, locally produced health solutions. The emphasis on a national industry for health products is a clear signal of the government's intent to leverage indigenous resources and expertise for economic development and public health.

This initiative is not merely about promoting traditional remedies but about integrating them into a structured, industrial framework. By doing so, MINRESI aims to ensure that the valorisation pharmacopée Cameroun contributes directly to the nation's productive capacity and its ability to meet its own health needs, thereby bolstering souveraineté sanitaire Cameroun.

The push by MINRESI for MINRESI pharmacopée traditionnelle Made in Cameroon signifies a potential shift in the landscape for pharmaceutical and health product companies operating within the country. The government's focus on developing a national industry for health and well-being products suggests forthcoming incentives and regulatory adjustments aimed at supporting local production and commercialization of traditional medicines. This could profoundly impact market access and intellectual property considerations for traditional knowledge.

Stakeholders in the health product sector, including legal advisors, should closely monitor the evolving regulatory environment concerning Cameroun médecine traditionnelle réglementation. The emphasis on valorisation pharmacopée Cameroun implies that new frameworks may be introduced to standardize, certify, and protect traditional medicinal products, ensuring their quality and efficacy while also safeguarding the knowledge of traditional practitioners. This move is critical for the growth of the industrie pharmaceutique locale Cameroun.

Ultimately, MINRESI's active promotion of traditional pharmacopoeia under the 'Made in Cameroon' banner is a strategic move to harness national heritage for economic and health benefits. It highlights a governmental commitment to fostering self-reliance in health product manufacturing, which will necessitate careful navigation of new legal and operational requirements for all entities involved in the development, production, and distribution of these increasingly recognized and regulated products.

Lawyers advising pharmaceutical, health product, or traditional medicine companies in Cameroon should monitor upcoming regulations and incentives from MINRESI regarding the development, production, and commercialization of traditional pharmacopoeia products, particularly those promoted under the 'Made in Cameroon' initiative. This signals potential shifts in market access, intellectual property considerations for traditional knowledge, and compliance requirements for local health products.

Source: Original reporting via Actu Cameroun